Phuong-thao L. Tran

Hanoi, Viet Nam

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies.

Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies.

Journal: Bioorganic & medicinal chemistry

Published: June 20, 2026

Correction to "Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence".

Correction to "Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence".

Journal: Journal of medicinal chemistry

Published: April 20, 2026

Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence.

Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence.

Journal: Journal of medicinal chemistry

Published: March 30, 2026

Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and Selectivity.

Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and Selectivity.

Journal: Journal of medicinal chemistry

Published: January 09, 2026

Novel imidazolium salts bearing 2-oxindoles scaffold as potent acetylcholinesterase inhibitors for Alzheimer's disease: Design, synthesis, in vitro and in silico studies.

Novel imidazolium salts bearing 2-oxindoles scaffold as potent acetylcholinesterase inhibitors for Alzheimer's disease: Design, synthesis, in vitro and in silico studies.

Journal: Bioorganic & medicinal chemistry letters

Published: October 21, 2025

Structural Optimization of Cn-AMP1 Enhances Antibacterial and Anticancer Potency With Low Hemolysis.

Structural Optimization of Cn-AMP1 Enhances Antibacterial and Anticancer Potency With Low Hemolysis.

Journal: Biopolymers

Published: September 13, 2025

Scaffold hopping yields novel furo[3,2-d]pyrimidine NNRTIs with optimized antiviral potency, enhanced selectivity, and reduced hERG liability.

Scaffold hopping yields novel furo[3,2-d]pyrimidine NNRTIs with optimized antiviral potency, enhanced selectivity, and reduced hERG liability.

Journal: Acta pharmaceutica Sinica. B

Published: September 10, 2025

Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles.

Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles.

Journal: Journal of medicinal chemistry

Published: August 14, 2025

Metal-polyphenol network-based multifunctional materials for tumor therapy: Intrinsic properties, advances, and applications.

Metal-polyphenol network-based multifunctional materials for tumor therapy: Intrinsic properties, advances, and applications.

Journal: Acta pharmaceutica Sinica. B

Published: April 23, 2025

Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease.

Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease.

Journal: RSC advances

Published: January 20, 2025

Searching for potential acetylcholinesterase inhibitors: a combined approach of multi-step similarity search, machine learning and molecular dynamics simulations.

Searching for potential acetylcholinesterase inhibitors: a combined approach of multi-step similarity search, machine learning and molecular dynamics simulations.

Journal: Royal Society open science

Published: April 04, 2024

Silver nanoparticles alter the dimerization of Aβ42 studied by REMD simulations.

Silver nanoparticles alter the dimerization of Aβ42 studied by REMD simulations.

Journal: RSC advances

Published: March 22, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026